1.
Camejo-Martínez N, Strazzarino-Peluffo N, Amarillo-Hernández D, Castillo-Leska C, Krygier-Waltier G. Initial clinical experience with ribociclib in advanced HR+/HER2− breast cancer in Uruguay. Rev Med Inst Mex Seguro Soc. 2026;64(3):e6704. doi:10.5281/zenodo.18715279